Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Frontiers in Immunology|June 26, 2026
Gut microbiota metabolites in inflammatory bowel disease: advances in mechanistic insightsYuhong Liang, Yingchen Zhou, Pei Luo, et al.
Frontiers in Molecular Biosciences|June 7, 2022
SMARCC1 Enters the Nucleus via KPNA2 and Plays an Oncogenic Role in Bladder CancerZhengmao Wei, Jinming Xu, Weiqing Li, et al.
Annals of Clinical and Laboratory Science|April 13, 2022
FAM107A as a Tumor Suppressor in Bladder Cancer Inhibits Cell Proliferation, Migration, and InvasionLonghua Ou, Zhengmao Wei, Jinming Xu, et al.
BMJ Public Health|April 1, 2026
Identifying barriers to human papillomavirus vaccination in China: a topic modelling analysis of social media (2018-2024)Zhijun Ding, Haoyun Yang, Yingchen Zhou, et al.
Acta Biochimica Et Biophysica Sinica|June 17, 2026
The tRNA landscape in cancer: from pathogenesis to therapeutic interventionsNi Jian, Han Ren, Yingqi Huang, et al.
Cancer Management and Research|October 16, 2020
TCEAL2 as a Tumor Suppressor in Renal Cell Carcinoma is Associated with the Good Prognosis of PatientsYingchen Zhou, Yang Zhang, Weiqing Li, et al.
Frontiers in Urology|October 29, 2025
Integrated management strategies for benign prostatic hyperplasiaYingchen Zhou, Qiao Luo, Ruixiao Wang, et al.
Communications Medicine|June 13, 2026
Deep learning analysis of trajectories and spatial variations in HPV vaccine discussions on Chinese WeiboYou Wang, Haoyun Yang, Zhijun Ding, et al.
The Journal of International Medical Research|October 7, 2021
Role of hypermethylated-lncRNAs in the prognosis of bladder cancer patientsJunhua Luo, Jinming Xu, Longhua Ou, et al.
Cell Death & Disease|July 3, 2021
FAM64A is an androgen receptor-regulated feedback tumor promoter in prostate cancerYingchen Zhou, Longhua Ou, Jinming Xu, et al.
Pageof 2